Clinical Trial Update: A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL [Phase 3]

View source ↗

Summary

A Phase III clinical trial evaluating HMPL-760 plus R-GemOx versus placebo plus R-GemOx for relapsed/refractory diffuse large B-cell lymphoma is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• HMPL-760
• R-GemOx (rituximab, gemcitabine, oxaliplatin)

Snippet

Sponsor: Hutchmed | Conditions: Relapsed/Refractory Diffuse Large B-Cell Lymphoma | Phase 3 | Status: RECRUITING